SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advanced Oxygen Technologies Inc – ‘10-Q’ for 12/31/19 – ‘EX-31.1’

On:  Monday, 1/27/20, at 1:52pm ET   ·   For:  12/31/19   ·   Accession #:  1731122-20-65   ·   File #:  0-09951

Previous ‘10-Q’:  ‘10-Q’ on 11/12/19 for 9/30/19   ·   Next:  ‘10-Q’ on 4/17/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 1/24/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/27/20  Advanced Oxygen Technologies Inc  10-Q       12/31/19   43:1.4M                                   Electro Filings LLC/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    164K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     15K 
16: R1          Document and Entity Information                     HTML     47K 
33: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML     91K 
43: R3          Condensed Consolidated Balance Sheets               HTML     39K 
                (Parenthetical)                                                  
21: R4          Condensed Consolidated Statement of Operations and  HTML     79K 
                Other Comprehensive Income (Loss) (Unaudited)                    
15: R5          Consolidated Statements of Stockholders' Equity     HTML     44K 
                (Unaudited)                                                      
32: R6          Consolidated Statements of Stockholders' Equity     HTML     20K 
                (Unaudited) (Parenthetical)                                      
42: R7          Condensed Consolidated Statements of Cash Flows     HTML     61K 
                (Unaudited)                                                      
20: R8          Organization and Line of Business                   HTML     20K 
17: R9          Summary of Significant Accounting Policies          HTML     29K 
30: R10         Revenue                                             HTML     20K 
41: R11         Leases                                              HTML     21K 
23: R12         Land                                                HTML     20K 
19: R13         Related Party Transactions                          HTML     18K 
29: R14         Notes Payable                                       HTML     24K 
40: R15         Shareholders' Equity                                HTML     26K 
22: R16         Subsequent Events                                   HTML     16K 
18: R17         Summary of Significant Accounting Policies          HTML     62K 
                (Policies)                                                       
31: R18         Revenue (Tables)                                    HTML     21K 
39: R19         Land (Tables)                                       HTML     19K 
28: R20         Notes Payable (Tables)                              HTML     19K 
13: R21         Organization and Line of Business (Details          HTML     17K 
                Narrative)                                                       
36: R22         Summary of Significant Accounting Policies          HTML     17K 
                (Details Narrative)                                              
38: R23         Revenue (Details)                                   HTML     19K 
27: R24         Land (Details)                                      HTML     18K 
12: R25         Land (Details Narrative)                            HTML     16K 
35: R26         Related Party Transactions (Details Narrative)      HTML     23K 
37: R27         Notes Payable (Details)                             HTML     32K 
26: R28         Notes Payable (Details Narrative)                   HTML     46K 
14: R29         Shareholders' Equity (Details Narrative)            HTML     74K 
24: XML         IDEA XML File -- Filing Summary                      XML     68K 
34: EXCEL       IDEA Workbook of Financial Reports                  XLSX     35K 
 6: EX-101.INS  XBRL Instance -- aoxy-20191231                       XML    365K 
 8: EX-101.CAL  XBRL Calculations -- aoxy-20191231_cal               XML     92K 
 9: EX-101.DEF  XBRL Definitions -- aoxy-20191231_def                XML    190K 
10: EX-101.LAB  XBRL Labels -- aoxy-20191231_lab                     XML    375K 
11: EX-101.PRE  XBRL Presentations -- aoxy-20191231_pre              XML    300K 
 7: EX-101.SCH  XBRL Schema -- aoxy-20191231                         XSD     66K 
25: ZIP         XBRL Zipped Folder -- 0001731122-20-000065-xbrl      Zip     49K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EXHIBIT 31.1

 

CERTIFICATIONS

 

I, Robert Wolfe, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q for the 6 month period ended December 31, 2020 of Advanced Oxygen Technologies, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the periods presented in this report;
   
4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

       
Date: January 27, 2020 By: /s/ Robert Wolfe  
    Robert Wolfe  
    Chief Executive Officer  

 

 

 


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
12/31/20None on these Dates
Filed on:1/27/20
For Period end:12/31/19
 List all Filings 
Top
Filing Submission 0001731122-20-000065   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., May 4, 4:00:23.1am ET